AIDS-related Kaposi sarcoma, version 2.2019: NCCN Clinical Practice Guidelines in Oncology Guidelines
| Authors: | Reid, E.; Suneja, G.; Ambinder, R. F.; Ard, K.; Baiocchi, R.; Barta, S. K.; Carchman, E.; Cohen, A.; Crysler, O. V.; Gupta, N.; Gustafson, C.; Hall, A.; Johung, K. L.; Klopp, A.; LaCasce, A. S.; Lin, C.; Mehta, A.; Menon, M. P.; Morgan, D.; Nathwani, N.; Noy, A.; Ratner, L.; Rizza, S.; Rudek, M. A.; Sanchez, J.; Taylor, J.; Tomlinson, B.; Wang, C. C. J.; Yendamuri, S.; Dwyer, M. A.; Freedman-Cass, D. A. |
| Title: | AIDS-related Kaposi sarcoma, version 2.2019: NCCN Clinical Practice Guidelines in Oncology |
| Abstract: | As treatment of HIV has improved, people living with HIV (PLWH) have experienced a decreased risk of AIDS and AIDS-defining cancers (non-Hodgkin’s lymphoma, Kaposi sarcoma, and cervical cancer), but the risk of Kaposi sarcoma in PLWH is still elevated about 500-fold compared with the general population in the United States. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for AIDS-Related Kaposi Sarcoma provide diagnosis, treatment, and surveillance recommendations for PLWH who develop limited cutaneous Kaposi sarcoma and for those with advanced cutaneous, oral, visceral, or nodal disease. © JNCCN—Journal of the National Comprehensive Cancer Network |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 17 |
| Issue: | 2 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2019-02-01 |
| Start Page: | 171 |
| End Page: | 189 |
| Language: | English |
| DOI: | 10.6004/jnccn.2019.0008 |
| PUBMED: | 30787130 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Source: Scopus |
